SABCS Snippets: Risk-Reducing Surgeries and Survival in Young BRCA Carriers

(6:)

SABCS Snippets: Results from the OlympiA Trial

(7:8)

SABCS Snippets: Results of the COMET Study (AFT-25)

(7:25)

SABCS Snippets: The Critical Value of Career Development Programs for Women in STEM

(4:22)

SABCS Snippets: Controversies in local regional care

(4:27)

SABCS Snippets: The multinational randomized controlled PREFERABLE-EFFECT study

(5:13)

SABCS Snippets: Results of the EMBER-3 Trial

(6:6)

SBL pre-seen debrief_Corjetz (SBL Pre-March 2025 mock)

(1:50:15)

SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA

(20:40)

Updates from the 2024 San Antonio Breast Cancer Symposium

(1:5:3)

SABCS Snippets: CNS disease updates

(4:54)

Adjuvant Therapy | 2023 Best of Breast Conference

(46:31)

The Hallmarks of Cancer - 12 Years On

(11:43)

Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)

(1:2:6)

SABCS Snippets: DESTINY-Breast06 Phase III Trial

(4:22)

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

(17:14)

🚨 SABCS 2024 EMBER-3 Trial Results | 🚨 Full Press Conference

(10:9)

SABCS Snippets: Mammographic surveillance in early breast cancer patients over 50

(2:46)

SABCS Snippets: Results from the AFT-38 PATINA Trial

(7:16)

SABCS Snippets: The US FDA Approval of Ribociclib

(5:32)

SABCS Snippets: After ASCO 2024

(20:17)

SABCS Snippets: Immunology in Hormone Receptor Positive Breast Cancer

(5:46)

SABCS Snippets: Chat with this year’s SABCS McGuire Awardee

(5:3)

SABCS Snippets: Shining a spotlight on Lobular Breast Cancer

(4:23)

SABCS Snippets: Primary Analysis of HER2CLIMB-02

(4:45)

SABCS Snippets: Magnetic Resonance Imaging and a 12-Gene Expression Assay

(5:55)

SABCS Snippets: Artificial Intelligence in the Clinic

(6:2)

SABCS Snippets: KEYNOTE-522 Phase 3 Results

(11:45)